• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新纽约手术死亡率风险评分在瓣膜和瓣膜/冠状动脉旁路移植手术中的验证。

Validation of new york operative mortality risk score for valve and valve/coronary artery bypass grafting operations.

机构信息

Medical Data Research Center, Providence Health & Services, Portland, Oregon 97225, USA.

出版信息

Ann Thorac Surg. 2013 Apr;95(4):1291-6. doi: 10.1016/j.athoracsur.2013.01.005. Epub 2013 Feb 28.

DOI:10.1016/j.athoracsur.2013.01.005
PMID:23453741
Abstract

BACKGROUND

New York (NY) valve and valve/coronary artery bypass grafting (CABG) mortality risk models, developed from operations performed in 2007 to 2009, have just been published. These models were validated using NY data from 2004 to 2006. The authors stated that their models "should also be validated by testing them against non-New York populations." Thus, we validated the NY models with the Providence Health & Services-Swedish Health Services (PH&S-SHS) cardiac surgical data and also compared them with The Society of Thoracic Surgeons (STS) mortality risk models.

METHODS

The PH&S-SHS validation data set contained 4,021 isolated valve and 2,406 valve/CABG operations, performed from 2008 to 2012. The risk models (NY logistic and score models and the STS models) were recalibrated to equalize the expected and observed number of deaths. Discrimination was tested by C statistics and calibration by Hosmer-Lemeshow statistics.

RESULTS

PH&S-SHS operative mortality rates were 2.6% and 5.5% in the valve and valve/CABG operations, respectively, and were lower than the NY rates. The C statistics for the NY logistic valve and valve/CABG models were 0.777 and 0.727, respectively, and were very similar for the NY score models. Calibration was good for the NY valve model (p=0.85), but not for the NY valve/CABG model (p=0.01). The STS models had better discrimination than NY models and good calibration.

CONCLUSIONS

The NY logistic and score models for valve operations fit the PH&S-SHS data well with acceptable discrimination and good calibration. The NY models for valve/CABG operations fit the PH&S-SHS data with acceptable discrimination and poor calibration. STS logistic regression models fit the PH&S-SHS data somewhat better.

摘要

背景

纽约(NY)瓣膜和瓣膜/冠状动脉旁路移植术(CABG)死亡率风险模型,由 2007 年至 2009 年进行的手术开发而来,刚刚公布。这些模型使用 2004 年至 2006 年的 NY 数据进行了验证。作者指出,他们的模型“也应该通过对非纽约人群进行测试来验证”。因此,我们使用普罗维登斯健康与服务-瑞典健康服务(PH&S-SHS)心脏手术数据验证了 NY 模型,并将其与胸外科医师学会(STS)死亡率风险模型进行了比较。

方法

PH&S-SHS 验证数据集包含 4021 例单纯瓣膜手术和 2406 例瓣膜/CABG 手术,于 2008 年至 2012 年进行。重新校准风险模型(NY 逻辑和评分模型以及 STS 模型)以平衡预期和观察到的死亡人数。通过 C 统计量测试区分度,并通过 Hosmer-Lemeshow 统计量测试校准。

结果

PH&S-SHS 瓣膜和瓣膜/CABG 手术的手术死亡率分别为 2.6%和 5.5%,低于 NY 率。NY 逻辑瓣膜和瓣膜/CABG 模型的 C 统计量分别为 0.777 和 0.727,NY 评分模型非常相似。NY 瓣膜模型的校准效果良好(p=0.85),但 NY 瓣膜/CABG 模型的校准效果不佳(p=0.01)。STS 模型的区分度优于 NY 模型,且校准效果良好。

结论

NY 逻辑和评分模型适用于瓣膜手术的 PH&S-SHS 数据,具有可接受的区分度和良好的校准。NY 模型适用于瓣膜/CABG 手术的 PH&S-SHS 数据,具有可接受的区分度和较差的校准。STS 逻辑回归模型对 PH&S-SHS 数据的拟合效果略好。

相似文献

1
Validation of new york operative mortality risk score for valve and valve/coronary artery bypass grafting operations.新纽约手术死亡率风险评分在瓣膜和瓣膜/冠状动脉旁路移植手术中的验证。
Ann Thorac Surg. 2013 Apr;95(4):1291-6. doi: 10.1016/j.athoracsur.2013.01.005. Epub 2013 Feb 28.
2
Risk score for predicting in-hospital/30-day mortality for patients undergoing valve and valve/coronary artery bypass graft surgery.用于预测行瓣膜手术和瓣膜/冠状动脉旁路移植手术患者院内/30 天死亡率的风险评分。
Ann Thorac Surg. 2013 Apr;95(4):1282-90. doi: 10.1016/j.athoracsur.2012.11.019. Epub 2013 Jan 24.
3
The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3--valve plus coronary artery bypass grafting surgery.胸外科医师协会2008年心脏手术风险模型:第3部分——瓣膜置换加冠状动脉搭桥手术
Ann Thorac Surg. 2009 Jul;88(1 Suppl):S43-62. doi: 10.1016/j.athoracsur.2009.05.055.
4
Do we need separate risk stratification models for hospital mortality after heart valve surgery?心脏瓣膜置换术后医院死亡率是否需要单独的风险分层模型?
Ann Thorac Surg. 2008 Mar;85(3):921-30. doi: 10.1016/j.athoracsur.2007.11.074.
5
First report on 30-day and operative mortality in risk model of isolated coronary artery bypass grafting in Japan.日本单纯冠状动脉搭桥术风险模型中30天和手术死亡率的首次报告。
Ann Thorac Surg. 2008 Dec;86(6):1866-72. doi: 10.1016/j.athoracsur.2008.08.001.
6
The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery.胸外科医师协会2008年心脏手术风险模型:第2部分——单纯瓣膜手术
Ann Thorac Surg. 2009 Jul;88(1 Suppl):S23-42. doi: 10.1016/j.athoracsur.2009.05.056.
7
Performance of EuroSCORE II in a large US database: implications for transcatheter aortic valve implantation.欧洲心脏手术风险评估系统II(EuroSCORE II)在美国大型数据库中的表现:对经导管主动脉瓣植入术的影响
Eur J Cardiothorac Surg. 2014 Sep;46(3):400-8; discussion 408. doi: 10.1093/ejcts/ezu033. Epub 2014 Feb 26.
8
The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery.胸外科医师协会2008年心脏手术风险模型:第1部分——冠状动脉搭桥手术
Ann Thorac Surg. 2009 Jul;88(1 Suppl):S2-22. doi: 10.1016/j.athoracsur.2009.05.053.
9
Good at One or Good at All? Variability of Coronary and Valve Operation Outcomes Within Centers.擅长一项还是擅长全部?中心内冠状动脉和瓣膜手术结果的可变性。
Ann Thorac Surg. 2018 Jun;105(6):1678-1683. doi: 10.1016/j.athoracsur.2017.12.038. Epub 2018 Jan 31.
10
A multi-centre additive and logistic risk model for in-hospital mortality following aortic valve replacement.一种用于主动脉瓣置换术后院内死亡的多中心相加和逻辑风险模型。
Eur J Cardiothorac Surg. 2007 Apr;31(4):607-13. doi: 10.1016/j.ejcts.2006.12.035. Epub 2007 Feb 6.